Analysis and modeling of the variable region of camelid single-domain antibodies
Open accessAbstract
Camelids have a special type of Ab, known as heavy chain Abs, which are devoid of classical Ab light chains. Relative to classical Abs, camelid heavy chain Abs (cAbs) have comparable immunogenicity, Ag recognition diversity and binding affinities, higher stability and solubility, and better manufacturability, making them promising candidates for alternate therapeutic scaffolds. Rational engineering of cAbs to improve therapeutic function requires knowledge of the differences of sequence and structural features between cAbs and classical Abs. In this study, amino acid sequences of 27 cAb variable regions (V(H)H) were aligned with the respective regions of 54 classical Abs to detect amino acid differences, enabling automatic identification of cAb V(H)H CDRs. CDR analysis revealed that the H1 often (and sometimes the H2) adopts diverse conformations not classifiable by established canonical rules. Also, although the cAb H3 is much longer than classical H3 loops, it often contains common structural motifs and sometimes a disulfide bond to the H1. Leveraging these observations, we created a Monte Carlo-based cAb V(H)H structural modeling tool, where the CDR H1 and H2 loops exhibited a median root-mean-square deviation to natives of 3.1 and 1.5 Å, respectively. The protocol generated 8-12, 14-16, and 16-24 residue H3 loops with a median root-mean-square deviation to natives of 5.7, 4.5, and 6.8 Å, respectively. The large deviation of the predicted loops underscores the challenge in modeling such long loops. cAb V(H)H homology models can provide structural insights into interaction mechanisms to enable development of novel Abs for therapeutic and biotechnological use.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nanobodies translate the same level of sequence variation into increased structural diversity across the CDRH1 and CDRH2 loops, which are not classifiable by established canonical rules, presenting additional challenges to computational structural modelling tools compared to classical antibodies.
“However, nanobodies translate this same level of sequence variation into increased structural diversity across the CDRH1 and CDRH2 loops, which are not classifiable by established canonical rules, presenting additional challenges to computational structural modelling tools compared to classical antibodies [232, 235].”
From Computational approaches to therapeutic antibody design: established methods and emerging trends (2020) · cites this paper as [235]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 65 · Cited by 92
Research works printed but not linked: 3
- [13]Muyldermans S Lauwereys M 1999 Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies J Mol Recognit 12 131 140 10398404
- [32]Al-Lazikani B Lesk AM Chothia C 1997 Standard conformations for the canonical structures of immunoglobulins J Mol Biol 273 927 948 9367782
- [54]Lo Conte L Chothia C Janin J 1999 The atomic structure of protein-protein recognition sites J Mol Biol 285 2177 2198 9925793
- Authors
- Sircar, A., Sanni, K. A., Shi, J., & Gray, J. J.
- Affiliations
- Johns Hopkins University (US)
- University of Maryland, Baltimore County (US)
- UCB Pharma (United Kingdom) (GB)
- Corresponding author
- Sircar, Aroop
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-01
- Volume
- 186
- Issue
- 11
- Pages
- 6357-6367
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3098910
- OpenAlex
- W2134668367
- Cited by
- 92
- References
- 65
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 10 · 2021: 7 · 2020: 8 · 2019: 12 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 4
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation (0647755)
- Johns Hopkins University
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM078221)
- UCB Pharma
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- camelid single-domain antibodies, heavy-chain antibodies, variable region, disulfide bonds, homology modeling
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Antibody, Camelids, New World, Camelus, Disulfides, Immunoglobulin Variable Region, Immunoglobulin Heavy Chains, Models, Molecular, Molecular Sequence Data, Protein Conformation, Sequence Homology, Amino Acid, Protein Structure, Secondary, Protein Structure, Tertiary, Protein Folding, Complementarity Determining Regions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review